State-of-the-Art Review: Antithrombotic Therapy Guidelines Specific to Individual Ischemic and Bleeding Risks An ‘Unmet Need’ in TAVR
There is an “unmet need” for antithrombotic therapy guidelines that are specific to the individual ischemic and bleeding risk of patients in the setting of transcatheter aortic valve replacement (TAVR), according to a new state-of-the-art review.